STOCK TITAN

Freenome: Perceptive reports 11.3% ownership stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Freenome, Inc. (FRNM) is the issuer whose common stock is covered by an amended beneficial-ownership report from Perceptive Advisors LLC, its managing member Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd., and C2 Life Sciences LLC. Perceptive Advisors and Edelman each reported shared voting and dispositive power over 12,606,053 shares, or 11.3%; these are overlapping attributed positions, not separate holdings. The Master Fund directly holds 12,518,597 shares (11.2%), while C2 directly holds 87,456 shares (0.1%). Neither Perceptive Advisors nor Edelman directly holds shares; each may be deemed to beneficially own shares held by the two entities. The reported percentages are based on 111,500,956 shares outstanding as of November 9, 2026. The statement's event date is September 30, 2026.

Beneficially owned shares 12,606,053 shares (11.3%) Perceptive Advisors LLC and Joseph Edelman each reported this overlapping position with shared voting and dispositive power.
Master Fund direct holdings 12,518,597 shares (11.2%) Shares directly held by Perceptive Life Sciences Master Fund, Ltd.
C2 direct holdings 87,456 shares (0.1%) Shares directly held by C2 Life Sciences LLC.
Common shares outstanding 111,500,956 shares As of November 9, 2026; basis for the reported ownership percentages.
beneficially own regulatory
"may be deemed to beneficially own shares held by the Master Fund and C2"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Shared Voting Power regulatory
"Shared Voting Power 12,606,053"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 12,606,053"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many FRNM shares did Perceptive Advisors report owning?

Perceptive Advisors LLC reported beneficial ownership of 12,606,053 Freenome common shares, or 11.3%, with shared voting and dispositive power. Joseph Edelman reported the same amount and percentage through the investment-management relationship; neither directly holds shares.

Which entities directly hold FRNM shares?

Perceptive Life Sciences Master Fund, Ltd. directly holds 12,518,597 shares, and C2 Life Sciences LLC directly holds 87,456 shares. Perceptive Advisors LLC serves as investment manager to both entities, and Joseph Edelman is Perceptive Advisors' managing member.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





35661P100

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:11/16/2026
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026
C2 Life Sciences LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026

Keep reading